LIGAND PHARMACEUTICALS INCORPORATED Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount of $1.11 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsForeign · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation, tax credit, foreign, amount for fiscal 2025 was $1.11M, a 65.50% decline from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation, tax credit, foreign, amount for fiscal 2024 was $3.23M.
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation, tax credit, foreign, amount for fiscal 2023 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED effective income tax rate reconciliation, tax credit, foreign, amount for fiscal 2022 was $0.00.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount 12 month |
|---|---|
| 2025-12-31 | $1.11M 10-K · filed 2026-02-27 |
| 2024-12-31 | $3.23M 10-K · filed 2026-02-27 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 |